Previous Article | Next Article ![]()
Journal of Clinical Microbiology, June 2005, p. 2866-2875, Vol. 43, No. 6
0095-1137/05/$08.00+0 doi:10.1128/JCM.43.6.2866-2875.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Department of Oncology and Surgical Sciences, Oncology Section, University of Padova, Padua,1 Unit of Infectious Diseases, General Hospital Careggi, Florence,2 Department of Medical and Surgical Sciences, University of Padova, Padua,3 Division of Nephrology II, Azienda Ospedaliera, Padua, Italy,4 Department of Virology, Hannover Medical School, Hannover, Germany,5 Immunology and Diagnostic Molecular Oncology, Azienda Ospedaliera, Padua, Italy6
Received 4 October 2004/ Returned for modification 23 December 2004/ Accepted 11 February 2005
Establishment of latently infected cell lines from primary effusion lymphomas (PEL) presently is the most efficient system for the propagation of clinical strains of human herpesvirus 8 (HHV-8) in culture. Here we describe a new approach to culture productively replicating HHV-8 from patient samples. A BJAB-derived B-cell line, BBF, was found to retain HHV-8 longer, to support the latent and lytic replication programs, and to produce transmissible virus. Supernatants from n-butyrate-treated peripheral blood mononuclear cells of 24 HHV-8-seropositive renal transplant recipients were used to infect BBF cells, and replicating virus was detected in cultures from 11 patients. Moreover, BBF cells infected with saliva strains showed a highly productive profile regardless of the initial viral load, which confirms that infectious HHV-8 can be present in saliva and also suggests that saliva strains may exhibit a high tropism for B lymphocytes. In conclusion, we established an in vitro system that efficiently detects HHV-8 in samples with low viral loads and that produces infectious progeny. BBF cells can be used to propagate HHV-8 from different biological samples as well as to clarify important issues related to virus-cell interactions in a context distinct from endothelial and PEL-derived cell lines.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|